Medpace Holdings, Inc. vs Johnson & Johnson
MEDP vs JNJ — side-by-side comparison from reported financials. MEDP leads 3, JNJ leads 6 of 9 comparable metrics.
Medpace Holdings, Inc.
MEDP · Healthcare
$612.05+1.55%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MEDP | JNJ |
|---|---|---|
| Price | $612.05 | $261.79 |
| Market cap | $17.1B | $631B |
| Revenue (TTM) | $2.78B | $97.9B |
| Revenue growth | +20.1% | +5.6% |
| Net margin | 17.7% | 21.5% |
| Free cash flow | $707M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +18.0% | +37.0% |
| P/E | 34.8 | 29.9 |
| P/E vs own history (cheap-side %) | 30% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 110% | 26% |
| CV checks passed | 8 of 10 | 10 of 10 |
| Employees | 6,500 | 140,800 |
Full résumé-style profiles: MEDP CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.